Evidence map›Paper›PMID 35662924›Full record

ArticleFrontiers in nutrition2022

Preservation of Anti-cytomegalovirus Activity in Human Milk Following High-Pressure Processing Compared to Holder Pasteurization.

Akash Kothari, Michael A Pitino, Sharon Unger, Véronique Perreault, Alain Doyen, Yves Pouliot, Allison J McGeer, Debbie Stone, Deborah L O'Connor

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. A Framework for Evaluation of New Processing Technologies in Human Milk Banking.Comprehensive reviews in food science and food safety · 2025
    Review
  3. Review
  4. Viruses and Human Milk: Transmission or Protection?Advances in nutrition (Bethesda, Md.) · 2023
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Akash KothariTranslational Medicine Program, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
Michael A PitinoTranslational Medicine Program, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
Sharon UngerDepartment of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Véronique PerreaultCentre de Recherche en Sciences et Technologie du Lait (STELA), Département des Sciences des Aliments et de Nutrition, Institut sur la Nutrition et les Aliments Fonctionnels, Université Laval, Quebec City, QC, Canada.
Alain DoyenCentre de Recherche en Sciences et Technologie du Lait (STELA), Département des Sciences des Aliments et de Nutrition, Institut sur la Nutrition et les Aliments Fonctionnels, Université Laval, Quebec City, QC, Canada.
Yves PouliotCentre de Recherche en Sciences et Technologie du Lait (STELA), Département des Sciences des Aliments et de Nutrition, Institut sur la Nutrition et les Aliments Fonctionnels, Université Laval, Quebec City, QC, Canada.
Allison J McGeerInstitute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Debbie StoneRogers Hixon Ontario Human Milk Bank, Sinai Health, Toronto, ON, Canada.
Deborah L O'ConnorTranslational Medicine Program, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pasteurized donor human milk is recommended for hospitalized preterm infants when mother's own milk is unavailable. Our aim was to compare the antiviral activity of human milk processed by Holder pasteurization (HoP) or high-pressure processing (HPP) against representative enveloped and non-enveloped viruses including cytomegalovirus and hepatitis A virus. Expressed milk from 20 donors collected from the Ontario Milk Bank was combined into 10 pools, each from two unique donors. Each pool was processed by HoP (62.5°C, 30 min) or HPP (500 MPa, 8 min, 4°C) and subsequently inoculated with cytomegalovirus or hepatitis A virus to achieve a final concentration of 5-log plaque-forming units/mL. Plaque reduction assays were used to quantify detectable virus after 30 min incubation (room temperature).

Indexed as

antiviralcytomegalovirus (CMV)donor human milkhepatitis A virus (HAV)high-pressure processing (HPP)Holder pasteurization

Identifiers

PMID35662924
PMCPMC9160983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.